News & Updates

Show Multimedia Only

Do hormonal contraceptives raise CRC risk in premenopausal women?

28 Jul 2026 by

The use of combined oral contraceptives, progestogen-only pills, or hormonal intrauterine devices neither protects against nor contributes to the risk of colorectal cancer (CRC) in premenopausal women, according to a study.

Do hormonal contraceptives raise CRC risk in premenopausal women?

28 Jul 2026

Patients with liver cirrhosis may sleep better with lemborexant

23 Jul 2026 by

Treatment with lemborexant helps manage sleep disturbances in patients with liver cirrhosis, as shown in the crossover RESTORE trial.

Patients with liver cirrhosis may sleep better with lemborexant

23 Jul 2026

Vedolizumab induces clinical remission in paediatric patients with UC

22 Jul 2026 by

Treatment with either low- or high-dose vedolizumab yields high rates of clinical remission in children with moderate-to-severe ulcerative colitis (UC), regardless of weight, according to the phase III KEPLER trial presented at ESPGHAN 2026.

Vedolizumab induces clinical remission in paediatric patients with UC

22 Jul 2026

Coffee may protect against liver disease, including cancer

21 Jul 2026 by

A recent study has shown an association between higher coffee intake and lower risks of cirrhosis, hepatocellular carcinoma (HCC), and liver-related mortality.

Coffee may protect against liver disease, including cancer

21 Jul 2026

Statins may protect against site-specific cancers

20 Jul 2026

Statin use may reduce the risk of cancer at several sites, including the liver, lung, colon, and rectum, especially for individuals with diabetes, as shown in a retrospective study.

Statins may protect against site-specific cancers

20 Jul 2026

$Maintenance upadacitinib efficacious in refractory paediatric UC$

Maintenance upadacitinib efficacious in refractory paediatric UC

19 Jul 2026 by

Maintenance treatment with upadacitinib helps sustain remission in children with refractory ulcerative colitis (UC), according to a retrospective study.

Maintenance upadacitinib efficacious in refractory paediatric UC

19 Jul 2026

Stopping anti-TNF therapy risky in paediatric IBD

18 Jul 2026 by

Paediatric inflammatory bowel disease (IBD) patients who have achieved clinical remission on tumour necrosis factor inhibitor (anti-TNF) therapy are likely to flare if they stop treatment, researchers from the IBD Porto Group of ESPGHAN have found.

Stopping anti-TNF therapy risky in paediatric IBD

18 Jul 2026

Coffee drinking may promote liver health

18 Jul 2026

High coffee intake may have protective effects on the liver, with reduced risk of cirrhosis, hepatocellular carcinoma (HCC), and liver-related mortality, as reported in a study.

Coffee drinking may promote liver health

18 Jul 2026

Elobixibat bests prucalopride for functional constipation in head-to-head trial

16 Jul 2026 by

Elobixibat delivers superior symptom relief and quality-of-life improvements compared with prucalopride in the second-line treatment of patients with functional constipation, as shown in a head-to-head trial.

Elobixibat bests prucalopride for functional constipation in head-to-head trial

16 Jul 2026

Bile acid reductions with odevixibat tied to improved LFTs in patients with PFIC2

16 Jul 2026 by

In individuals receiving odevixibat for progressive familial intrahepatic cholestasis 2 (PFIC2), also known as bile salt export pump (BSEP) deficiency, reductions in serum bile acid (sBA) levels correlated with improvements in key liver function tests (LFTs), according to a post hoc subgroup analysis presented at ESPGHAN 2026.

Bile acid reductions with odevixibat tied to improved LFTs in patients with PFIC2

16 Jul 2026

News & Updates

Showing Gastroenterology articles

Showing

Specialty:

Do hormonal contraceptives raise CRC risk in premenopausal women?

Do hormonal contraceptives raise CRC risk in premenopausal women?

Patients with liver cirrhosis may sleep better with lemborexant

Patients with liver cirrhosis may sleep better with lemborexant

Vedolizumab induces clinical remission in paediatric patients with UC

Vedolizumab induces clinical remission in paediatric patients with UC

Coffee may protect against liver disease, including cancer

Coffee may protect against liver disease, including cancer

Statins may protect against site-specific cancers

Statins may protect against site-specific cancers

Maintenance upadacitinib efficacious in refractory paediatric UC

Maintenance upadacitinib efficacious in refractory paediatric UC

Stopping anti-TNF therapy risky in paediatric IBD

Stopping anti-TNF therapy risky in paediatric IBD

Coffee drinking may promote liver health

Coffee drinking may promote liver health

Elobixibat bests prucalopride for functional constipation in head-to-head trial

Elobixibat bests prucalopride for functional constipation in head-to-head trial

Bile acid reductions with odevixibat tied to improved LFTs in patients with PFIC2

Bile acid reductions with odevixibat tied to improved LFTs in patients with PFIC2